Vol.21 No.6

Rapid Communication

Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks

Authors

Isamu Yokoe1 , Shinya Nishio1 , Hiroshi Sato1 , Hitomi Kobayashi1

  • Division of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo, 174-0051, Japan
Received:

7 January 2011

Accepted:

9 May 2011

Published online:

8 June 2011

Full Text

PDF　(member's only)

Abstract

Without Abstract

Key words

Interleukin-6 (IL-6) - Matrix metalloproteinase-3 (MMP-3) - Tumor necrosis factor (TNF)